iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · Real-Time Price · USD
2.670
+0.080 (3.09%)
At close: Nov 1, 2024, 4:00 PM
2.570
-0.100 (-3.75%)
After-hours: Nov 1, 2024, 7:55 PM EDT
iBio, Inc. Employees
iBio, Inc. had 16 employees as of June 30, 2024. The number of employees decreased by 10 or -38.46% compared to the previous year.
Employees
16
Change (1Y)
-10
Growth (1Y)
-38.46%
Revenue / Employee
$14,063
Profits / Employee
-$1,556,688
Market Cap
24.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
Precision Optics Corporation | 85 |
Pieris Pharmaceuticals | 50 |
Inspira Technologies Oxy B.H.N. | 42 |
Palatin Technologies | 30 |
Unity Biotechnology | 19 |
Onconetix | 12 |
RenovoRx | 8 |
IBIO News
- 6 weeks ago - iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - iBio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development - GlobeNewsWire
- 5 months ago - iBio Closes Sale of Manufacturing Facility in Texas - GlobeNewsWire
- 6 months ago - iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - iBio stock nearly tripled on Wednesday: here's why - Invezz
- 7 months ago - iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases - GlobeNewsWire
- 7 months ago - iBio Announces $15.0 Million Private Placement - GlobeNewsWire